(Q51183535)

English

Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices.

scientific article published on 12 June 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Selective upregulation of beta1-adrenergic receptors and dephosphorylation of troponin I in end-stage heart failure patients supported by ventricular assist devices. (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

0 references

13

object named as

Burkert Pieske

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

author name string

Hendrik Milting

1

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Christian Scholz

2

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Latif Arusoglu

3

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Meike Freitag

4

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Ramona Cebulla

5

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Kornelia Jaquet

6

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Reiner Körfer

7

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Dirk V Lewinski

8

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Astrid Kassner

9

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Otto-Erich Brodde

10

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Harald Kögler

11

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Aly El Banayosy

12

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

publication date

12 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

41

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

3

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

441-450

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

The molecular basis for distinct beta-adrenergic receptor subtype actions in cardiomyocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Beta-adrenergic receptor subtypes differentially affect apoptosis in adult rat ventricular myocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Myocardial beta-adrenoceptor changes in heart failure: concomitant reduction in beta 1- and beta 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Distinct down-regulation of cardiac beta 1- and beta 2-adrenoceptors in different human heart diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Diminished responsiveness of Gs-coupled receptors in severely failing human hearts: no difference in dilated versus ischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Increased Ca2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Reverse remodeling in heart failure ? fact or fiction?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Mechanical unloading restores beta-adrenergic responsiveness and reverses receptor downregulation in the failing human heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Myocardial gene transfer and overexpression of beta2-adrenergic receptors potentiates the functional recovery of unloaded failing hearts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Bridge to recovery with the use of left ventricular assist device and clenbuterol

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Age-dependent changes in the beta-adrenoceptor-G-protein(s)-adenylyl cyclase system in human right atrium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Microanalysis and distribution of cardiac troponin I phospho species in heart areas

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

The time course of natriuretic hormones as plasma markers of myocardial recovery in heart transplant candidates during ventricular assist device support reveals differences among device types.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Hemodynamic exercise testing reveals a low incidence of myocardial recovery in LVAD patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Differential regulation of mRNA specific for beta 1- and beta 2-adrenergic receptors in human failing hearts. Evaluation of the absolute cardiac mRNA levels by two independent methods

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Selective regulation of beta 1- and beta 2-adrenoceptors in the human heart by chronic beta-adrenoceptor antagonist treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Reduction of beta-adrenoceptor density and evaluation of positive inotropic responses in isolated, diseased human myocardium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

The 3' untranslated region of messenger RNA: A molecular 'hotspot' for pathology?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Post-transcriptional regulation of gene expression by degradation of messenger RNAs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Agonist-mediated destabilization of human beta1-adrenergic receptor mRNA: role of the 3' untranslated translated region

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Agonist regulation of human beta2-adrenergic receptor mRNA stability occurs via a specific AU-rich element

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Protein phosphorylation in isolated trabeculae from nonfailing and failing human hearts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Effect of the Implantable Left Ventricular Assist Device on Neuroendocrine Activation in Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

The structural examination of myocardial samples from patients with end-stage heart failure supported by ventricular assist devices using electron microscopy and amino acid analysis reveals low degree of reverse remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2006.04.010

7 January 2021

Identifiers

10.1016/J.YJMCC.2006.04.010

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 March 2018

http://europepmc.org/abstract/MED/16765375

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51183535&oldid=1370930210"